UNSPSC 51271804: Quatacaine

This classification denotes an anesthetic agent with the molecular formula C14H22N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 49BR7256ZY, chemically known as propanamide, 2-methyl-n-(2-methylphenyl)-2-(propylamino)- but generally known as quatacaine, which bears US NIH Compound Identifier 65685. European Medicines Agency schedules Quatacaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10187MIG.

UNSPSC 51271804 Quatacaine is a Commodity code covering local anesthetic pharmaceutical products sold to state and local government health systems, corrections facilities, and public health agencies through cooperative purchasing agreements. State and local procurement under this code flows primarily through multistate cooperative purchasing vehicles rather than direct institutional solicitations, with vendors supplying pharmaceutical manufacturers' products via authorized wholesaler networks to participating jurisdictions. The scope includes finished pharmaceutical products with specific National Drug Codes (NDCs), requiring manufacturers or authorized distributors to meet cGMP certification, Drug Supply Chain Security Act (DSCSA) compliance, FDA registration, and contractual relationships with designated wholesalers maintaining chargeback systems.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued a Request for Proposal on January 20, 2026 (RFP S1070000015802) to establish multiple-award contracts for generic multi-source pharmaceuticals and over-the-counter products effective July 1, 2026, with proposals due March 26, 2026. The solicitation spans participating state and local government facilities across Minnesota and Oregon, requiring vendors to supply products through three authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., LLC). Award evaluation weights price competitiveness at 75 percent, with 10 percent for fixed pricing, 5 percent each for administrative compliance, EDI capability, and agreement to a 3 percent administrative fee. Vendors must carry $5 million commercial general liability insurance, $2 million network security and privacy liability, and $2 million professional liability, with contract terms of two years for new responders and extensions through June 30, 2028 for incumbents. The RFP does not identify specific set-aside designations or budget ranges.